Jul 25 2019 Johns Hopkins Medicine and University of Alabama at Birmingham (UAB) researchers will lead a multicenter, multinational study of acute flaccid myelitis (AFM), the “poliolike” condition affecting children that causes loss of muscle control. The National Institutes of Health’s National Institute of Allergy and Infectious Diseases awarded an approximate $10 million contract to
0 Comments
Researchers from the United Kingdom have appraised the most recent assessment by the European Food Safety Authority regarding the safety of aspartame, a popular type of artificial sweetener. The investigators caution that the commission’s findings may be misleading. Is aspartame really as safe as official reports claim? Some researchers are unsure. Aspartame is perhaps the
0 Comments
A researcher in a Bristol-Myers Squibb laboratory. The drugs — ipilimumab (brand name Yervoy) and nivolumab (Opdivo) — belong to a class called checkpoint inhibitors and are made by Bristol-Myers Squibb. Emile Wamsteker | Bloomberg | Getty Images Bristol-Myers released mixed results on Wednesday from trials testing the survival benefit of its immunotherapy Opdivo in combination
0 Comments
Air pollution concentrations within or below current air quality standards have contributed to thousands of deaths in the U.S. from cardiorespiratory causes, researchers reported. In the nationwide and county level analysis accessing the impact of particulate matter pollution (PM2.5) concentrations on mortality and health, as many as 30,000 deaths in the U.S. could be attributed
0 Comments
Researchers have found that severe malnutrition is associated with lower exposure to the antimalarial drug lumefantrine in children treated with artemether-lumefantrine, the most common treatment, for uncomplicated falciparum malaria. The study, which is the first to specifically address this, has been published in Clinical Pharmacology and Therapeutics. It calls urgently for further research into optimized
0 Comments
Researchers from Germany and Switzerland have recently investigated the possible associations between conditions relating to mental health, such as depression and anxiety, and the presence of different types of allergy. Their findings, they say, should prompt scientists to pay more attention to these links. New research identifies an association between generalized anxiety and the presence
0 Comments
New research finds that the immunotherapy drug teplizumab delays the onset of type 1 diabetes by 2 years, on average, in high-risk individuals. New research has significant clinical implications, particularly for young people with a high risk of type 1 diabetes. Type 1 diabetes is an autoimmune disease affecting about 1.25 million children and adults
0 Comments
An extensive meta-analysis provides comprehensive evidence that consistently following a healthful, plant-based diet could help lower the risk of type 2 diabetes. Data on thousands of individuals indicate that having a plant-based diet may help reduce the risk of type 2 diabetes. According to data from the Centers of Disease Control and Prevention (CDC), more
0 Comments
People with cancer have trouble accessing appropriate psychological support, a new global report published today by the All.Can international cancer initiative reveals. Patient insights on cancer care: opportunities for improving efficiency reveals findings from the international All.Can patient survey, in which seven out of ten respondents (69%) said they needed psychological support either during or
0 Comments
earn free cme credit Earn CME credit by reading this article and completing the posttest. Sign Up Study Authors: Christopher C. Butler, David Gillespie, et al.; Allan S. Brett, Majdi N. Al-Hasan Target Audience and Goal Statement: Infectious disease specialists, pulmonologists, emergency physicians, hospitalists, primary care physicians The goal was to find out if point-of-care-testing
0 Comments
Dementia is a problem of the elderly, right? Generally that’s true. But there is one form of the disease that can strike people when they are very young, in their twenties or even their teens. It’s called Frontotemporal Dementia, or FTD. And while rare, it devastates lives by rapidly turning young, vital people into those
0 Comments